Literature DB >> 3098486

Total parenteral nutrition in mice bearing a metastatic carcinoma: tumor growth, metastasis and immunologic parameters.

M D Cohen, M Bryant, E M Copeland, S M Mahaffey, K J Kao, T G Baumgartner, C I Wei, H S Sitren.   

Abstract

The role of dietary manipulation of tumor growth, metastasis and immunologic parameters was studied in mice bearing Lewis lung carcinoma. Fourteen days following subcutaneous tumor implant, groups with tumor and their non-tumor bearing counterparts were assigned to one of the following feeding protocols: total parenteral nutrition (TPN), per oral (PO) intake of the parenteral diet, an oral casein diet (CAS), or electrolyte infusion plus the casein diet (ELECT). Intakes of energy and nitrogen were similar among all groups. Mice were killed 12 days later and peritoneal macrophages were tested for phagocytic activity. Tumor growth and metastasis were decreased from both infusion regimens with minimal loss of body weight as compared with casein fed mice. PO mice also showed lower tumor weight but metastasis was as great as in the casein group. Non-tumor-bearing infused mice showed depressed thymic weight, but thymic weight was not further reduced in tumor-bearing infused mice. PO feeding afforded no such protection in the presence of the carcinoma. Splenomegaly was observed in tumor-bearing mice on all regimens, but mice maintained on the parenteral diet demonstrated the largest proportion of macrophages containing nuclear debris. Analysis of free macrophages indicated no effect of diet regimen on non-immune phagocytic activity in both tumor-free and tumor-bearing mice. Possible alteration of splenic macrophage intracellular digestive capacity or phagocytic activity was suggested as a result of TPN.

Entities:  

Mesh:

Year:  1986        PMID: 3098486     DOI: 10.1007/bf00133590

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  26 in total

1.  Effect of ammonium metavanadate on the murine immune response.

Authors:  M D Cohen; C I Wei; H Tan; K J Kao
Journal:  J Toxicol Environ Health       Date:  1986

2.  Prevention by splenectomy of thymus weight depletion in the presence of progressively growing tumor in rats: Brief communication.

Authors:  J D Meyer; J A Meyer
Journal:  J Natl Cancer Inst       Date:  1977-09       Impact factor: 13.506

3.  Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. I. Histology and weight of lymph nodes, spleen, and thymus.

Authors:  A J Edwards; M R Sumner; G F Rowland; C M Hurd
Journal:  J Natl Cancer Inst       Date:  1971-08       Impact factor: 13.506

Review 4.  Immunological factors in nutritional assessment.

Authors:  R Dionigi
Journal:  Proc Nutr Soc       Date:  1982-09       Impact factor: 6.297

5.  Nutritional regulation of immunity and infection in the gastrointestinal tract.

Authors:  R K Chandra
Journal:  J Pediatr Gastroenterol Nutr       Date:  1983       Impact factor: 2.839

Review 6.  Immunocompetence as a functional index of nutritional status.

Authors:  R K Chandra
Journal:  Br Med Bull       Date:  1981-01       Impact factor: 4.291

7.  Attachment and phagocytosis studies with murine pulmonary alveolar macrophages.

Authors:  G L Fisher; K L McNeill; C B Whaley; J Fong
Journal:  J Reticuloendothel Soc       Date:  1978-09

8.  Immune response and leucine oxidation in oral and intravenous fed rats.

Authors:  R H Birkhahn; C M Renk
Journal:  Am J Clin Nutr       Date:  1984-01       Impact factor: 7.045

9.  Effects of diets deficient in glucose and glucose precursors on the growth of the Walker carcinosarcoma 256 in rats.

Authors:  W L Dills; E Kwong; T R Covey; M C Nesheim
Journal:  J Nutr       Date:  1984-11       Impact factor: 4.798

10.  The effect of energy substrate manipulation on tumor growth and metastasis and intermediary metabolism in the parenterally fed mouse.

Authors:  S M Mahaffey; E M Copeland; E Economides; J L Talbert; T G Baumgartner; H S Sitren
Journal:  J Pediatr Surg       Date:  1985-12       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.